Tag: Tuberculosis

On India's commitment towards ending TB by 2025, the Union health minister said that under its G20 Presidency, the country diligently advocated & addressed selected concerns of global importance

Officially launched during the 46th edition of MICROCON in Lucknow, the test identifies individuals with latent TB who are at risk of developing active infection and treating them is a crucial component of the disease elimination

Indian TB Patients are still waiting for the BPaL Treatment Regimen despite its acceptance in 70 countries

The Cover Story analyzes the launch of Global Biofuel Alliance at G20 Summit with Expert Insights by Dr Syed Shams Yazdani, Group Leader, ICGEB-New Delhi. Read a series of power-packed interviews featuring Raghav Priyadarshi, CEO, Savikalpa Sciences; Amit Gandhi, CBO, DeepTek.ai; and Anuj Kumbhat, CEO, WRMS. Startup Special story features Mumbai based HaystackAnalytics.

The inclusion of Serum-Mylab's Cy-TB in the NTEP and its availability on the Ni-kshay platform marks a substantial leap forward in the country's TB control efforts.

Reports have continued to surface indicating a severe shortage of essential anti-TB medications, including Linezolid, Clofazimine, and Cycloserine

With a staggering 2.64 million reported cases in 2022, tuberculosis remains a formidable public health challenge

The new program aims to spread awareness and enhance treatment adherence among TB patients in India

SATB is urging swift and immediate action from the Ministry of Health and Family Welfare to resolve this situation

First phase of the Never Stop Screening project reached over 1 million individuals in the Northern belt, screening 12,000 people with TB symptoms